Treatment of keratin intermediate filaments with sulfur mustard analogs

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 616-621

  Hess, John F ^a   FitzGerald, Paul G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intermediate filament; Keratin; Keratin intermediate filament; kIF; Mustard gas; Skin blistering; Sulfur mustard

Indexed keywords

CHLORMETHINE; CHLOROETHYL ETHYL SULFIDE; KERATIN; MUSTARD GAS DERIVATIVE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL; BLISTER; CELL DESTRUCTION; CONTROLLED STUDY; CYTOLYSIS; EPIDERMIS CELL; INTERMEDIATE FILAMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

ANIMALS; CATTLE; HUMANS; KERATINS; MUSTARD GAS;

EID: 34250213869     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.141     Document Type: Article

References (42)

1. Dacre J.C., and Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol. Rev. 48 (1996) 289-326
2. Momeni A.Z., Enshaeih S., Meghdadi M., and Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas [see comments]. Arch. Dermatol. 128 (1992) 775-780
3. Smith K.J., Hurst C.G., Moeller R.B., Skelton H.G., and Sidell F.R. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J. Am. Acad. Dermatol. 32 (1995) 765-776
4. Requena L., Requena C., Sanchez M., Jaqueti G., Aguilar A., Sanchez-Yus E., and Hernandez-Moro B. Chemical warfare. Cutaneous lesions from mustard gas. J. Am. Acad. Dermatol. 19 (1988) 529-536
5. Wormser U. Toxicology of mustard gas. Trends Pharmacol. Sci. 12 (1991) 164-167
6. Smith W.J., and Dunn M.A. Medical defense against blistering chemical warfare agents. Arch. Dermatol. 127 (1991) 1207-1213
7. Smith W.J., Cowan F.M., and Broomfield C.A. Increased proteolytic activity in human epithelial cells following exposure to sulfur mustard. FASEB J. 5 (1991) 828
8. Cowan F.M., Broomfield C.A., and Smith W.J. Effect of sulfur exposure on protease activity in human peripheral blood lymphocytes. Cell Biol. Toxicol. 7 (1991) 239-248
9. Chakrabarti A.K., Ray P., Broomfield C.A., and Ray R. Purification and characterization of protease activated by sulfur mustard in normal human epidermal keratinocytes. Biochem. Pharmacol. 56 (1998) 467-472
10. Shakarjian M.P., Bhatt P., Gordon M.K., Chang Y.C., Casbohm S.L., Rudge T.L., Kiser R.C., Sabourin C.L., Casillas R.P., Ohman-Strickland P., Riley D.J., and Gerecke D.R. Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J. Appl. Toxicol. 26 3 (2006) 239-246
11. Chakrabarti A.K., and Ray P. Novel endogenous inhibitor of sulfur mustard-stimulated protease in cultured human epidermal keratinocytes: possible application in vesicant intervention. J. Appl. Toxicol. 20 Suppl. 1 (2000) S59-S61
12. Ray P., Chakrabarti A.K., Broomfield C.A., and Ray R. Sulfur mustard-stimulated protease: a target for antivesicant drugs. J. Appl. Toxicol. 22 (2002) 139-140
13. Monteiro-Riviere N.A., and Inman A.O. Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin. Microsc. Res. Tech. 37 (1997) 229-241
14. Monteiro-Riviere N.A., Inman A.O., Babin M.C., and Casillas R.P. Immunohistochemical characterization of the basement membrane epitopes in bis(2-chloroethyl) sulfide-induced toxicity in mouse ear skin. J. Appl. Toxicol. 19 (1999) 313-328
15. Werrlein R.J., and Madren-Whalley J.S. Multiphoton microscopy: an optical approach to understanding and resolving sulfur mustard lesions. J. Biomed. Opt. 8 (2003) 396-409
16. Werrlein R.J., and Madren-Whalley J.S. Effects of sulfur mustard on the basal cell adhesion complex. J. Appl. Toxicol. 20 Suppl. 1 (2000) S115-S123
17. Dillman III J.F., McGary K.L., and Schlager J.J. Sulfur mustard induces the formation of keratin aggregates in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 193 (2003) 228-236
18. Zhang Z., Peters B.P., and Monteiro-Riviere N.A. Assessment of sulfur mustard interaction with basement membrane components. Cell Biol. Toxicol. 11 (1995) 89-101
19. Irvine A.D., and McLean W.H.I. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br. J. Dermatol. 140 (1999) 815-828
20. Ross W.C.J. Biological Alkylating Agents (1962), Butterworth, London
21. Wheeler G.P. Studies related to the mechanisms of action of cytotoxic alkylating agents: a review. Cancer Res. 22 (1962) 651-688
22. Byrne M.P., Broomfield C.A., and Stites W.E. Mustard gas crosslinking of proteins through preferential alkylation of cysteines. J. Protein Chem. 15 (1996) 131-136
23. Goodlad G.A. Esterification of protein and amino acid carboxyl groups by mustard gas and related compounds. Biochim. Biophys. Acta 24 (1957) 645-646
24. Moore S., Stein W.H., and Fruton J.S. Chemical reactions of mustard gas and related compounds. II. The reaction of mustard gas with carboxy groups and with the amino groups of amino acids and peptides. J. Org. Chem. 11 (1946) 675-680
25. Herriott R.M., Anson M.L., and Northrup J.H. Reaction of enzymes and proteins with mustard gas. J. Gen. Physiol. 30 (1946) 185-210
26. Davis S.B., and Ross W.F. The reaction of mustard gas with proteins. J. Am. Chem. Soc. 69 (1947) 1177-1185
27. Noort D., Verheij E.R., Hulst A.G., de Jong L.P., and Benschop H.P. Characterization of sulfur mustard induced structural modifications in human hemoglobin by liquid chromatography--tandem mass spectrometry. Chem. Res. Toxicol. 9 (1996) 781-787
28. Carter J.M., Hutcheson A.M., and Quinlan R.A. In vitro studies on the assembly properties of the lens proteins CP49, CP115: coassembly with alpha-crystallin but not with vimentin. Exp. Eye Res. 60 (1995) 181-192
29. Baxter M.A., Chahwala S.B., Hickman J.A., and Spurgin G.E. The effects of nitrogen mustard (HN2) on activities of the plasma membrane of PC6A mouse plasmacytoma cells. Biochem. Pharmacol. 31 (1982) 1773-1778
30. Kim Y.B., Lee Y.S., Choi D.S., Cha S.H., and Sok D.E. Inactivation of microsomal Ca(2+)-ATPase by 2-chloroethylethyl sulfide. Chem. Biol. Interact. 97 (1995) 239-246
31. van der Schans G.P., Noort D., Mars-Groenendijk R.H., Fidder A., Chau L.F., de Jong L.P., and Benschop H.P. Immunochemical detection of sulfur mustard adducts with keratins in the stratum corneum of human skin. Chem. Res. Toxicol. 15 (2002) 21-25
32. Steinert P.M., and Parry D.A. The conserved H1 domain of the type II keratin 1 chain plays an essential role in the alignment of nearest neighbor molecules in mouse and human keratin 1/keratin 10 intermediate filaments at the two- to four-molecule level of structure. J. Biol. Chem. 268 (1993) 2878-2887
33. Coulombe P.A., and Fuchs E. Elucidating the early stages of keratin filament assembly. J. Cell Biol. 111 (1990) 153-169
34. Rogers K.R., Herrmann H., and Franke W.W. Characterization of disulfide crosslink formation of human vimentin at the dimer, tetramer, and intermediate filament levels. J. Struct. Biol. 117 (1996) 55-69
35. Geisler N., Schunemann J., and Weber K. Chemical crosslinking indicates a staggered and antiparallel protofilament of desmin intermediate filaments and characterizes one higher level complex between protofilaments. Eur. J. Biochem. 206 (1992) 841-852
36. Quinlan R.A., Cohlberg J.A., Schiller D.L., Hatzfeld M., and Franke W.W. Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cells. J. Mol. Biol. 178 (1984) 365-388
37. Tabor S., and Richardson C.C. A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc. Natl. Acad. Sci. USA 82 (1985) 1074-1078
38. Hess J.F., Voss J.C., and FitzGerald P.G. Real-time observation of coiled-coil domains and subunit assembly in intermediate filaments. J. Biol. Chem. 277 (2002) 35516-35522
39. Nagai K., and Thøgersen H.C. Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli. Methods Enzymol. 153 (1987) 461-481
40. Hess J.F., Budamagunta M.S., Shipman R.L., FitzGerald P.G., and Voss J.C. Characterization of the linker 2 region in human vimentin using site-directed spin labeling and electron paramagnetic resonance. Biochemistry 45 (2006) 11737-11743
41. Hess J.F., Budamagunta M.S., Fitzgerald P.G., and Voss J.C. Characterization of structural changes in vimentin bearing an epidermolysis bullosa simplex-like mutation using site-directed spin labeling and electron paramagnetic resonance. J. Biol. Chem. 280 (2005) 2141-2146
42. Hess J.F., Budamagunta M.S., Voss J.C., and Fitzgerald P.G. Structural characterization of human vimentin rod 1 and the sequencing of assembly steps in intermediate filament formation in vitro using site-directed spin labeling and electron paramagnetic resonance. J. Biol. Chem. 279 (2004) 44841-44846